BioSpace News Archive

Nuvo Pharmaceuticals Inc., today announced that its wholly owned subsidiary, Nuvo Pharmaceuticals Limited has entered into a license and supply agreement with Fagron Belgium NV for the exclusive right to register, distribute, market and sell Resultz® in Belgium, the Netherlands and Luxembourg.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced it has received U.S. Food and Drug Administration (FDA) approval on its Abbreviated New Drug Application for a generic version of Potassium Chloride oral solution.

Highly Respected Industry Veteran to Provide Expertise and Counsel.

Aerie Pharmaceuticals, Inc., today announced that the $125 million of senior secured convertible notes held by affiliates of Deerfield Management Company L.P. since September 2014 have been fully converted into 5,040,323 shares of Aerie common stock...

Tolero Pharmaceuticals, Inc. today announced that it has initiated the second stage of the Phase 2 Zella 201 study evaluating the efficacy and safety of alvocidib, a potent CDK9 inhibitor, in combination with cytarabine and mitoxantrone in patients with relapsed or refractory MCL-1-dependent acute myeloid leukemia.

Bridge Medicines announced today an agreement with Memorial Sloan Kettering (MSK) to develop a platform designed to deliver drugs specifically to the kidney.

Presentations highlight a novel multifactorial approach to the treatment of Alzheimer’s Disease

Clinical studies with Biocept’s Target Selector™ to evaluate the use of circulating tumor cells in disease assessment, surveillance and monitoring

Henry Schein, Inc. announced that it will release its second quarter 2018 financial results before the stock market opens on Monday, August 6, 2018, and will provide a live webcast of its earnings conference call on the same day, beginning at 10:00 a.m. Eastern time.

Results Compare the Blockstent Microcatheter™ to Commercially Available Vascular Plugs and Coils